ALTHX.PA

Strong SellSinker

THX Pharma Société Anonyme · Healthcare · France · $71M · Avg Vol: $386K/d

Sinker: Weak, expensive and falling. Nothing here to keep it afloat.

9
StockRank
Get insider-trade alerts
Quality
16
Value
21
Momentum
45
P/E (TTM)
—
peers 22.9x
ROE
-482.4%
peers -33.6%
D/E
1.0x
peers 0.4x
Dividend %
—
trailing yield
Director trades · 180d
None →
Buybacks · 180d
None →

ABOUT THX PHARMA SOCIÉTÉ ANONYME

Read

THX Pharma (formerly Phaxiam Therapeutics) is a clinical-stage biotechnology company developing innovative therapies using bacteriophages to combat antimicrobial resistance. The company's competitive moat lies in its advanced phage therapy platform and extensive library of natural phages targeting highly resistant bacterial infections. It is a specialized niche player addressing a critical global health threat.

FINANCIAL SUMMARY (EUR)

Year20212022202320242025CAGRTTM
Revenue—0000——
EPS (EUR)-1.63-0.45-0.87-0.22-0.22—-0.22
Shares—14.4M7.8M8.5M13.8M-4.7%14.4M
Debt—4.9M3.6M2.9M2.9M-16.2%2.9M
Equity—5.7M2.2M-1.7M2.9M-20.3%—
Op CF—-5.4M-6.4M-3.4M-0.8M—-0.9M
Inv CF—0.3M-61.1K77.0K-0.2M——
Fin CF—1.6M2.2M-0.6M7.8M——
Loading 1Y...
PRICE (1Y)-27.9%
3.724.114.504.885.27Aug 4Aug 26Sep 16
SMA 50SMA 200

Close
$3.75
RSI (14)
12.4
52W High
$5.86
From 52W High
0.6%

SCORE BREAKDOWN

Quality
16
ROIC
-84.5%8.6
ROE
-482.4%1.7
GP/Assets
-13.3%5.9
Op. Margin
-144876610.0%0.0
FCF/Assets
-10.2%29.0
Piotroski
438.8
Int. Cover
-39.2x13.2
D/E Ratio
0.99x14.0
Current Ratio
2.35x46.1
Value
21
P/E (TTM)
—N/A
EV/EBITDA
-10.8x25.0
P/FCF
—N/A
P/B
16.3x6.5
P/S
61.5x8.4
Div Yield
—N/A
Momentum
45
52W High %
64%41.6
RS 6M
1%64.5
SMA 50/200
1.24x90.9
EPS Rev 4W
-0.9%24.9
EPS Rev 12W
+1.7%71.2
EPS Improve
-736%0.6
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$71M
P/E (Forward)
-1.9x
Gross Margin
—

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALTHX.PA are excluded.

TickerCompanyMkt CapStockRankSignal
ALTHX.PATHX Pharma Société Anonyme(you)$71M9Strong Sell
OSE.PAOSE Immunotherapeutics SA$89M4Strong Sell
ALGAE.PAFermentalg SA$64M21Sell
ADOC.PAAdocia SA$94M0Strong Sell
ABNX.PAABIONYX Pharma SA$100M1Strong Sell
ALSEN.PASensorion SA$162M3Strong Sell
IPHAInnate Pharma S.A.$248M16Strong Sell
CLLSCellectis S.A.$342M6Strong Sell
TNG.PATransgene SA$259M18Strong Sell
VALNValneva SE$610M12Strong Sell

Peer medians: ROE -33.6% · P/E 22.9x · Gross margin 72.6%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

THX Pharma Société Anonyme (ALTHX.PA): Stock Score Summary

THX Pharma Société Anonyme (ALTHX.PA) has a MoatMap StockRank of 9/100 based on Quality (16/100), Value (21/100), and Momentum (45/100) factor scores. The current signal is STRONG SELL.

THX Pharma (formerly Phaxiam Therapeutics) is a clinical-stage biotechnology company developing innovative therapies using bacteriophages to combat antimicrobial resistance. The company's competitive moat lies in its advanced phage therapy platform and extensive library of natural phages targeting highly resistant bacterial infections. It is a specialized niche player addressing a critical global health threat.

Key Financial Metrics

Price$3.75
Market Cap$71M
P/E (Forward)-1.86
Price/Book16.33
Return on Equity-482.4%
Return on Invested Capital-84.5%
Debt/Equity0.99x
Operating Margin-144876610.0%
Revenue Growth-100.0%
Free Cash Flow$-1M

THX Pharma Société Anonyme operates in the Biotechnology industry, part of the Healthcare sector (France).

Frequently Asked Questions

What is THX Pharma Société Anonyme’s (ALTHX.PA) StockRank?
MoatMap’s StockRank for THX Pharma Société Anonyme (ALTHX.PA) is 9/100, with a Strong Sell signal. It is a composite of Quality (16), Value (21), and Momentum (45) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does THX Pharma Société Anonyme have an economic moat?
THX Pharma Société Anonyme (ALTHX.PA) has a Quality factor score of 16/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is THX Pharma Société Anonyme a buy, hold, or sell?
MoatMap’s current signal for THX Pharma Société Anonyme (ALTHX.PA) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is THX Pharma Société Anonyme in?
THX Pharma Société Anonyme (ALTHX.PA) operates in the Healthcare sector, specifically the Biotechnology industry (France).
Browse all ranked stocksALTHX.PA deep dive reportAI ChampionsHow we score stocksSense-check another stock